Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -98.59x is 117% below its 5-year average of -45.54x, near the high end of its 5-year range (-883.00x–22.81x).
35.94% above its 12-month average of -153.90x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -1.13x.
INTEREST COVERAGE RATIO
-98.59x
INTEREST COVERAGE RATIO AVG TTM
-153.90x
INTEREST COVERAGE RATIO AVG 3Y
-51.94x
INTEREST COVERAGE RATIO AVG 5Y
-45.54x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+35.94%
CURRENT VS 3Y AVG
-89.80%
CURRENT VS 5Y AVG
-116.50%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.79x
median of 488 covered companies
CURRENT VS SECTOR MEDIAN
-1602.76%
vs the sector median at left
NEXGEL, Inc.
Market Cap
$1.43M
Interest Coverage Ratio
-98.59x
TTM Avg
-153.90x
3Y Avg
-51.94x
5Y Avg
-45.54x
Market Cap
$1.43M
Interest Coverage Ratio
-4.49x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.48M
Interest Coverage Ratio
-13.48x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.38M
Interest Coverage Ratio
-58.78x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.50M
Interest Coverage Ratio
-37.39x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.29M
Interest Coverage Ratio
-134.94x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NEXGEL, Inc. (NXGL) | $1.43M | -98.59x | -153.90x | -51.94x | -45.54x |
| INVO Fertility, Inc. (IVF)vs › | $1.43M | -4.49x | N/A | N/A | N/A |
| Curis, Inc. (CRIS)vs › | $1.47M | -15.06x | N/A | N/A | N/A |
| PMGC Holdings Inc. (ELAB)vs › | $1.48M | -13.48x | N/A | N/A | N/A |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.38M | -58.78x | N/A | N/A | N/A |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.50M | -37.39x | N/A | N/A | N/A |
| Genprex, Inc. (GNPX)vs › | $1.34M | -20.97x | N/A | N/A | N/A |
| NewcelX Ltd. (NCEL)vs › | $1.32M | -0.41x | N/A | N/A | N/A |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.29M | -134.94x | N/A | N/A | N/A |
| Silo Pharma, Inc. (SILO)vs › | $1.65M | -114.76x | N/A | N/A | N/A |
Interest Coverage
-98.6x
Debt/Equity
1.51
Current Ratio
0.43
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -1.13x |
| 2026-03-31 | 22.81x |
| 2025-12-31 | -607.00x |
| 2025-06-30 | -30.29x |
| 2025-03-31 | -37.00x |
| 2024-12-31 | -52.56x |
| 2024-09-30 | -39.40x |
| 2024-06-30 | -35.13x |
| 2024-03-31 | -58.07x |
| 2023-12-31 | -243.80x |
| 2023-09-30 | -204.00x |
| 2023-06-30 | -84.67x |
| 2023-03-31 | -883.00x |
| 2022-12-31 | -390.50x |
| 2022-09-30 | -4.29x |
| 2022-06-30 | -2.06x |
| 2022-03-31 | -1.09x |
| 2021-12-31 | -1.01x |
| 2021-09-30 | -1.14x |
| 2021-06-30 | -1.31x |
| 2021-03-31 | -3.15x |
| 2020-12-31 | -135.20x |
| 2020-09-30 | -41.15x |
| 2020-03-31 | -509.00x |
